Bone Biologics Corp BBLG shares are trading lower by 12% to $0.54 Monday morning on downward momentum after the company last week announced it's conducting a public offering and private placement to sell over a million shares of its common stock at $0.64 each, alongside unregistered warrants to purchase more shares.
What Else?
H.C. Wainwright & Co. is overseeing the offering, which is expected to generate around $729,200. The funds will be used for clinical trials, expanding patents, and general operational requirements.
The offering should finalize by around November 20, pending standard conditions. Warrants, priced at $0.52 per share, can be exercised for five and a half years after issuance.
See Also: What's Going On With Microsoft Stock Monday?
According to data from Benzinga Pro, BBLG has a 52-week high of $13.21 and a 52-week low of $0.47.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
